Area of research
Epidemiology · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Medicine, Pregnancy, Breastfeeding, Biology, Cardiotoxicity, and Anthracycline.
Infant drug exposure via breast milk
Cognitive and behavioral risk factors for low quality of life in survivors of childhood acute lymphoblastic leukemia
Quantitative MRI outcomes in child and adolescent leukemia survivors: Evidence for global alterations in gray and white matter
Takeuchi M, Kobayashi T, Biss T, Kamali F, Vear SI, Ho RH, Bajolle F, Loriot M-A, Shaw K, Carleton BC, Hamberg A-K, Wadelius M, Hirono K, Taguchi M, Wakamiya T, Yanagimachi M, Hirai K, Itoh K, Brandeo LR, Ito S . CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin
— 2019cited by 0position: selected
Reasons for substance use continuation and discontinuation during pregnancy: A qualitative study
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations
Substance Use in Pregnancy Among Vulnerable Women Seeking Addiction and Parenting Support
Delaney S, Malik P, Stefan C, Edginton A, Colantonio D, Ito S. Predicting escitalopram exposure to breastfeeding infants: integrating analytical and in silico techniques for risk assessment. Clin Pharmacokinet 2018; 57 (12): 1603-1611
— 2018cited by 0position: selected
Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
Panchaud A, Garcia-Bournissen F, Csajka C, Kristensen JH, Taddio A, Ilet KF, Begg EJ, Ito S . Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine. Clin Pharmacol Ther 2011;89: 830–836 . PMID: 21525869
— 2011cited by 0position: selected
Tan KP, Wang B, Yang M, Boutros PC, MacAulay J, Xu H, Chuang AI, Kosuge K, Yamamoto M, Takahashi S, Wu A, Ross DD, Harper PA, Ito S . Aryl hydrocarbon receptor (AHR) is a transcriptional activator of human breast cancer resistance protein (BCRP/ABCG2). Mol Pharmacol 2010;78:175-185 PMID
— 2010cited by 0position: selected
Ito S. Drug therapy for breast-feeding women. New Engl J Med 2000; 343:118-126. PMID: 10891521
— 2000cited by 0position: selected